ECOG's Active Protocols - Protocols active on 03/11/10

ECOG Protocols Active as of 03/11/10

Click on the protocol number to view the NCI's PDQ description of the protocol.

Protocol	Title
E1F05	Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma Activation Date: 21-dec-2006 Suspended: 24-feb-2010
E3F05	Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas Activation Date: 11-sep-2009
N0574	Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in PAtients with One to Three Cerebral Metastases Activation Date: 08-aug-2006
NCCTGN0577	Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma Activation Date: 22-sep-2009
RTOG0825	A Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Activation Date: 22-apr-2009